TD Private Client Wealth LLC Decreases Stake in Encompass Health Co. (NYSE:EHC)

TD Private Client Wealth LLC cut its holdings in shares of Encompass Health Co. (NYSE:EHC) by 66.1% during the fourth quarter, HoldingsChannel.com reports. The fund owned 2,485 shares of the company’s stock after selling 4,851 shares during the period. TD Private Client Wealth LLC’s holdings in Encompass Health were worth $229,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of the business. Xponance Inc. lifted its position in Encompass Health by 6.0% during the fourth quarter. Xponance Inc. now owns 11,417 shares of the company’s stock worth $1,054,000 after buying an additional 651 shares in the last quarter. Intech Investment Management LLC raised its holdings in shares of Encompass Health by 31.0% during the 4th quarter. Intech Investment Management LLC now owns 17,514 shares of the company’s stock worth $1,617,000 after acquiring an additional 4,143 shares during the period. Thrivent Financial for Lutherans boosted its position in shares of Encompass Health by 16.9% during the 4th quarter. Thrivent Financial for Lutherans now owns 888,827 shares of the company’s stock valued at $82,083,000 after acquiring an additional 128,331 shares during the last quarter. Counterpoint Mutual Funds LLC grew its holdings in shares of Encompass Health by 53.4% in the fourth quarter. Counterpoint Mutual Funds LLC now owns 4,187 shares of the company’s stock valued at $387,000 after purchasing an additional 1,458 shares during the period. Finally, Signaturefd LLC increased its position in Encompass Health by 21.6% during the fourth quarter. Signaturefd LLC now owns 704 shares of the company’s stock worth $65,000 after purchasing an additional 125 shares during the last quarter. Hedge funds and other institutional investors own 97.25% of the company’s stock.

Wall Street Analyst Weigh In

EHC has been the subject of several analyst reports. Barclays increased their price target on shares of Encompass Health from $116.00 to $118.00 and gave the company an “overweight” rating in a research note on Friday, February 7th. KeyCorp raised their target price on Encompass Health from $117.00 to $120.00 and gave the stock an “overweight” rating in a research note on Monday, February 10th. StockNews.com raised Encompass Health from a “hold” rating to a “buy” rating in a research note on Saturday, February 15th. Royal Bank of Canada reissued an “outperform” rating and set a $110.00 price objective on shares of Encompass Health in a research report on Tuesday, February 11th. Finally, William Blair reaffirmed an “outperform” rating on shares of Encompass Health in a research report on Friday, February 7th. Ten analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Buy” and a consensus price target of $107.67.

Encompass Health Stock Up 0.8 %

Shares of EHC opened at $100.71 on Wednesday. The company’s 50-day simple moving average is $98.28 and its 200-day simple moving average is $97.26. The company has a debt-to-equity ratio of 0.84, a quick ratio of 1.04 and a current ratio of 1.05. Encompass Health Co. has a 1 year low of $76.11 and a 1 year high of $104.55. The stock has a market capitalization of $10.14 billion, a PE ratio of 22.58, a P/E/G ratio of 2.31 and a beta of 0.92.

Encompass Health (NYSE:EHC) last issued its quarterly earnings results on Thursday, February 6th. The company reported $1.17 EPS for the quarter, beating the consensus estimate of $1.05 by $0.12. Encompass Health had a net margin of 8.48% and a return on equity of 17.56%. Analysts forecast that Encompass Health Co. will post 4.8 earnings per share for the current fiscal year.

Encompass Health Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 15th. Stockholders of record on Tuesday, April 1st will be given a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.68%. The ex-dividend date of this dividend is Tuesday, April 1st. Encompass Health’s dividend payout ratio is presently 15.25%.

Insider Buying and Selling

In other Encompass Health news, CAO Andrew L. Price sold 5,042 shares of the stock in a transaction that occurred on Thursday, February 13th. The shares were sold at an average price of $98.29, for a total value of $495,578.18. Following the sale, the chief accounting officer now directly owns 69,164 shares of the company’s stock, valued at approximately $6,798,129.56. This represents a 6.79 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this link. Insiders own 2.10% of the company’s stock.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.